1. Home
  2. BDSX vs RAND Comparison

BDSX vs RAND Comparison

Compare BDSX & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • RAND
  • Stock Information
  • Founded
  • BDSX 2005
  • RAND 1969
  • Country
  • BDSX United States
  • RAND United States
  • Employees
  • BDSX N/A
  • RAND N/A
  • Industry
  • BDSX Precision Instruments
  • RAND Finance: Consumer Services
  • Sector
  • BDSX Health Care
  • RAND Finance
  • Exchange
  • BDSX Nasdaq
  • RAND Nasdaq
  • Market Cap
  • BDSX 53.2M
  • RAND 54.4M
  • IPO Year
  • BDSX 2020
  • RAND N/A
  • Fundamental
  • Price
  • BDSX $6.21
  • RAND $15.21
  • Analyst Decision
  • BDSX Strong Buy
  • RAND
  • Analyst Count
  • BDSX 5
  • RAND 0
  • Target Price
  • BDSX $35.00
  • RAND N/A
  • AVG Volume (30 Days)
  • BDSX 273.2K
  • RAND 5.0K
  • Earning Date
  • BDSX 10-31-2025
  • RAND 11-05-2025
  • Dividend Yield
  • BDSX N/A
  • RAND 11.03%
  • EPS Growth
  • BDSX N/A
  • RAND N/A
  • EPS
  • BDSX N/A
  • RAND N/A
  • Revenue
  • BDSX $76,556,000.00
  • RAND $7,966,118.00
  • Revenue This Year
  • BDSX $18.80
  • RAND N/A
  • Revenue Next Year
  • BDSX $27.76
  • RAND N/A
  • P/E Ratio
  • BDSX N/A
  • RAND N/A
  • Revenue Growth
  • BDSX 25.70
  • RAND 1.16
  • 52 Week Low
  • BDSX $3.44
  • RAND $13.82
  • 52 Week High
  • BDSX $37.00
  • RAND $31.89
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 51.49
  • RAND 46.04
  • Support Level
  • BDSX $0.37
  • RAND $14.50
  • Resistance Level
  • BDSX $8.40
  • RAND $15.25
  • Average True Range (ATR)
  • BDSX 0.92
  • RAND 0.66
  • MACD
  • BDSX -0.06
  • RAND 0.03
  • Stochastic Oscillator
  • BDSX 55.98
  • RAND 31.70

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.

Share on Social Networks: